Potential role and therapeutic interests of myo-inositol in metabolic diseases

Biochimie

Volumn 95, Issue 10, 2013, Pages 1811-1827

  Croze, Marine L ^a   Soulage, Christophe O ^a  

^a UNIVERSITÉ DE LYON   (France)

Author keywords

Diabetes; Diabetic neuropathy; Inositol; Insulin resistance; Metabolic syndrome; Polycystic ovary syndrome

Indexed keywords

INOSITOL;

DIABETES MELLITUS; DIABETIC NEUROPATHY; DIET SUPPLEMENTATION; HUMAN; INSULIN RESISTANCE; KIDNEY DISEASE; METABOLIC DISORDER; OVARY POLYCYSTIC DISEASE; PREGNANCY DIABETES MELLITUS; REVIEW;

ANIMALIA;

1-D-MYO-INOSITOL-PHOSPHATE SYNTHASE; 5′ AMP-ACTIVATED PROTEIN KINASE; AC; ACC; ACETYL-COENZYME A CARBOXYLASE; ADENOSINE MONOPHOSPHATE; ADENYLYL CYCLASE; ADVANCED GLYCATION END PRODUCTS; AGES; AMP; AMPK; AREA UNDER THE CURVE; AUC; BMI; BODY MASS INDEX; CAMP; CDP-DAG; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASE; CYTIDINE DIPHOSPHATE-DIACYLGLYCEROL; D-CHIRO-INOSITOL; DCI; DIABETES; DIABETIC NEUROPATHY; ECM; EXTRACELLULAR MATRIX; FA; FOLIC ACID; FOLLICLE-STIMULATING HORMONE; FSH; G3PAT; GESTATIONAL DIABETES MELLITUS; GFR; GK; GLOMERULAR FILTRATION RATE; GLUCOSE TRANSPORTER 4; GLUT-4; GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE; GLYCOGEN SYNTHASE; GLYCOGEN SYNTHASE KINASE 3; GLYCOSYL PHOSPHATIDYLINOSITOL; GMD; GOTO KAKIZAKI (RAT); GPI; GS; GSK3; H(+)/MYO-INOSITOL TRANSPORTER; HDL; HEXOKINASE; HIGH DENSITY LIPOPROTEIN; HK; HMIT; HOMA-IR; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; IMPASE; INOSITOL; INOSITOL MONOPHOSPHATASE; INOSITOL PHOSPHATES (INCLUDING IN PARTICULAR: INS-P: INOSITOL MONOPHOSPHATE, IP3, INOSITOL TRIPHOSPHATES, IP6, INOSITOL HEXAKISPHOSPHATES OR PHYTIC ACID); INOSITOL PHOSPHOGLYCAN; INS-2; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE(S); INSULIN RESISTANCE; INSULIN SECOND MESSENGER WITH A 4-O-(2-AMINO-2-DEOXY-BETA-D-GALACTOPYRANOSYL)-3-O-METHYL-D-CHIRO-INOSITOL STRUCTURE; IPG; IPS; IR; IRS; LD50; LDL; LH; LOW DENSITY LIPOPROTEIN; LUTEINIZING HORMONE; LYSOPHOSPHATIDYLINOSITOL; LYSOPI; MAMMALIAN TARGET OF RAPAMYCIN; MEDIAN LETHAL DOSE; METABOLIC SYNDROME; METS; MI; MIOX; MIPS; MNCV; MOTOR NERVE CONDUCTION VELOCITY; MTOR; MYO-INOSITOL; MYO-INOSITOL OXYGENASE; OGTT; ORAL GLUCOSE TOLERANCE TEST; PCOS; PDH; PDHP; PDK; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLINOSITOL PHOSPHATE LIPIDS (INCLUDING PIP(2), PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE AND PIP(3), PHOSPHATIDYLINOSITOL (3,4,5)-TRISPHOSPHATE); PHOSPHATIDYLINOSITOL-3-KINASE(S); PHOSPHOINOSITIDE-DEPENDENT KINASE; PHOSPHOLIPASE C; PHOSPHOLIPASE D; PHOSPHOPROTEIN PHOSPHATASE 2C ALPHA; PI; PI3K; PIPS; PKA; PKB; PKC; PLC; PLD; POLYCYSTIC OVARY SYNDROME; PP-INSPS; PP2CΑ; PROTEIN KINASE B; PROTEIN KINASE C; PYROPHOSPHATE FORMS OF INOSITOL PHOSPHATES; PYRUVATE DEHYDROGENASE; PYRUVATE DEHYDROGENASE PHOSPHATASE; RANDOMIZED CONTROLLED TRIAL; RCT; SEX HORMON BINDING GLOBULIN; SHBG; SHR; SMIT1/2; SODIUM-DEPENDANT MYO-INOSITOL TRANSPORTER 1/2; SPONTANEOUSLY HYPERTENSIVE RAT; STREPTOZOTOCIN; STZ;

ANIMALS; BLOOD GLUCOSE; CATARACT; DIABETES, GESTATIONAL; DIABETIC NEPHROPATHIES; DIET; FEMALE; HUMANS; INOSITOL; INSULIN; INSULIN RESISTANCE; METABOLIC SYNDROME X; POLYCYSTIC OVARY SYNDROME; PREGNANCY;

EID: 84883255949     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2013.05.011     Document Type: Review

References (110)

1. H. Eagle, V.I. Oyama, M. Levy, and A. Freeman myo-Inositol as an essential growth factor for normal and malignant human cells in tissue culture Science 123 1956 845 847
2. J.F.L. Chau, M.K. Lee, J.W.S. Law, S.K. Chung, and S.S.M. Chung Sodium/myo-inositol cotransporter-1 is essential for the development and function of the peripheral nerves FASEB J. 19 2005 1887 1889
3. Z. Dai, S.K. Chung, D. Miao, K.S. Lau, A.W.H. Chan, and A.W.C. Kung Sodium/myo-inositol cotransporter 1 and myo-inositol are essential for osteogenesis and bone formation J. Bone Miner. Res. 26 2011 582 590
4. G. Carlomagno, M. Nordio, T.T. Chiu, and V. Unfer Contribution of myo-inositol and melatonin to human reproduction Eur. J. Obstet. Gynecol. Reprod. Biol. 159 2011 267 272
5. R.A. Condorelli, S. La Vignera, S. Bellanca, E. Vicari, and A.E. Calogero Myoinositol: does it improve sperm mitochondrial function and sperm motility? Urology 79 2012 1290 1295
6. L. Ciotta, M. Stracquadanio, I. Pagano, A. Carbonaro, M. Palumbo, and F. Gulino Effects of myo-inositol supplementation on oocyte's quality in PCOS patients: a double blind trial Eur. Rev. Med. Pharmacol. Sci. 15 2011 509 514
7. V. Unfer, G. Carlomagno, P. Rizzo, E. Raffone, and S. Roseff myo-Inositol rather than d-chiro-inositol is able to improve oocyte quality in intracytoplasmic sperm injection cycles A prospective, controlled, randomized trial Eur. Rev. Med. Pharmacol. Sci. 15 2011 452 457
8. R.A. Condorelli, S. La Vignera, F. Di Bari, V. Unfer, and A.E. Calogero Effects of myoinositol on sperm mitochondrial function in-vitro Eur. Rev. Med. Pharmacol. Sci. 15 2011 129 134
9. P. Beemster, P. Groenen, and R. Steegers-Theunissen Involvement of inositol in reproduction Nutr. Rev. 60 2002 80 87
10. H.K. Ortmeyer, L.C. Huang, L. Zhang, B.C. Hansen, and J. Larner Chiroinositol deficiency and insulin resistance II acute effects of d-chiroinositol administration in streptozotocin-diabetic rats, normal rats given a glucose load, and spontaneously insulin-resistant rhesus monkeys Endocrinology 132 1993 646
11. H.K. Ortmeyer, J. Larner, and B.C. Hansen Effects of d-chiroinositol added to a meal on plasma glucose and insulin in hyperinsulinemic rhesus monkeys Obes. Res. 3 Suppl. 4 1995 605S 608S
12. H.K. Ortmeyer Dietary myoinositol results in lower urine glucose and in lower postprandial plasma glucose in obese insulin resistant rhesus monkeys Obes. Res. 4 1996 569 575
13. V. Unfer, G. Carlomagno, G. Dante, and F. Facchinetti Effects of myo-inositol in women with PCOS: a systematic review of randomized controlled trials Gynecol. Endocrinol. 28 2012 509 515
14. B.J. Holub Metabolism and function of myo-inositol and inositol phospholipids Annu. Rev. Nutr. 6 1986 563 597
15. U. Schlemmer, W. Frølich, R.M. Prieto, and F. Grases Phytate in foods and significance for humans: food sources, intake, processing, bioavailability, protective role and analysis Mol. Nutr. Food Res. 53 Suppl. 2 2009 S330 S375
16. R.S. Clements, and B. Darnell myo-Inositol content of common foods: development of a high-myo-inositol diet Am. J. Clin. Nutr. 33 1980 1954 1967
17. L.M. Lewin, Y. Yannai, S. Sulimovici, and P.F. Kraicer Studies on the metabolic role of myo-inositol distribution of radioactive myo-inositol in the male rat Biochem. J. 156 1976 375 380
18. R.M. Deranieh, and M.L. Greenberg Cellular consequences of inositol depletion Biochem. Soc. Trans. 37 2009 1099 1103
19. H. Fu, B. Li, L. Hertz, and L. Peng Contributions in astrocytes of SMIT1/2 and HMIT to myo-inositol uptake at different concentrations and pH Neurochem. Int. 61 2012 187 194
20. B.A. Molitoris, I.E. Karl, and W.H. Daughaday Concentration of myo-inositol in skeletal muscle of the rat occurs without active transport J. Clin. Invest. 65 1980 783 788
21. X. Lin, L. Ma, R.L. Fitzgerald, and R.E. Ostlund Jr. Human sodium/inositol cotransporter 2 (SMIT2) transports inositols but not glucose in L6 cells Arch. Biochem. Biophys. 481 2009 197 201
22. F. Eisenberg Jr., and A.H. Bolden Biosynthesis of inositol in rat testis homogenate Biochem. Biophys. Res. Commun. 12 1963 72 77
23. G. Hauser, and V.N. Finelli The biosynthesis of free and phosphatide myo-inositol from glucose by mammalian tissue slices J. Biol. Chem. 238 1963 3224 3228
24. P.H. Meng, C. Raynaud, G. Tcherkez, S. Blanchet, K. Massoud, S. Domenichini, Y. Henry, L. Soubigou-Taconnat, C. Lelarge-Trouverie, P. Saindrenan, J.P. Renou, and C. Bergounioux Crosstalks between myo-inositol metabolism, programmed cell death and basal immunity in Arabidopsis PLoS One 4 2009 e7364
25. Y. Pak, L.C. Huang, K.J. Lilley, and J. Larner In vivo conversion of [3H]myoinositol to [3H]chiroinositol in rat tissues J. Biol. Chem. 267 1992 16904 16910
26. P.P. Hipps, W.H. Holland, and W.R. Sherman Interconversion of myo- and scyllo-inositol with simultaneous formation of neo-inositol by an NADP+ dependent epimerase from bovine brain Biochem. Biophys. Res. Commun. 77 1977 340 346
27. T. Takenawa, and K. Egawa CDP-diglyceride:inositol transferase from rat liver purification and properties J. Biol. Chem. 252 1977 5419 5423
28. J.A. Benjamins, and B.W. Agranoff Distribution and properties of CDP-diglyceride:inositol transferase from brain J. Neurochem. 16 1969 513 527
29. C.F. Howard Jr., and L. Anderson Metabolism of myo-inositol in animals II complete catabolism of myo-inositol-14C by rat kidney slices Arch. Biochem. Biophys. 118 1967 332 339
30. Inositol Material Safety Data Sheet MSDS Number 12480 1996
31. S. Lam, A. McWilliams, J. LeRiche, C. MacAulay, L. Wattenberg, and E. Szabo A phase I study of myo-inositol for lung cancer chemoprevention Cancer Epidemiol. Biomarkers Prev. 15 2006 1526 1531
32. G. Carlomagno, and V. Unfer Inositol safety: clinical evidences Eur. Rev. Med. Pharmacol. Sci. 15 2011 931 936
33. A.I. Winegrad Banting lecture 1986 does a common mechanism induce the diverse complications of diabetes? Diabetes 36 1987 396 406
34. H.-H.G. Chang Mechanisms Underlying the Abnormal Inositol Metabolisms in Diabetes Mellitus Thesis, ResearchSpace@Auckland 2011
35. A.S. Kennington, C.R. Hill, J. Craig, C. Bogardus, I. Raz, H.K. Ortmeyer, B.C. Hansen, G. Romero, and J. Larner Low urinary chiro-inositol excretion in non-insulin-dependent diabetes mellitus N. Engl. J. Med. 323 1990 373 378
36. T. Sun, D.B. Heimark, T. Nguygen, J.L. Nadler, and J. Larner Both myo-inositol to chiro-inositol epimerase activities and chiro-inositol to myo-inositol ratios are decreased in tissues of GK type 2 diabetic rats compared to Wistar controls Biochem. Biophys. Res. Commun. 293 2002 1092 1098
37. I. Asplin, G. Galasko, and J. Larner chiro-Inositol deficiency and insulin resistance: a comparison of the chiro-inositol- and the myo-inositol-containing insulin mediators isolated from urine, hemodialysate, and muscle of control and type II diabetic subjects Proc. Natl. Acad. Sci. U. S. A. 90 1993 5924 5928
38. D.A. Greene, and S.A. Lattimer Sodium- and energy-dependent uptake of myo-inositol by rabbit peripheral nerve competitive inhibition by glucose and lack of an insulin effect J. Clin. Invest. 70 1982 1009 1018
39. M.A. Yorek, and J.A. Dunlap The effect of elevated glucose levels on myo-inositol metabolism in cultured bovine aortic endothelial cells Metab. Clin. Exp. 38 1989 16 22
40. B. Olgemöller, S. Schwaabe, E.D. Schleicher, and K.D. Gerbitz Competitive inhibition by glucose of myo-inositol incorporation into cultured porcine aortic endothelial cells Biochim. Biophys. Acta 1052 1990 47 52
41. M. Haneda, R. Kikkawa, T. Arimura, K. Ebata, M. Togawa, S. Maeda, T. Sawada, N. Horide, and Y. Shigeta Glucose inhibits myo-inositol uptake and reduces myo-inositol content in cultured rat glomerular mesangial cells Metab. Clin. Exp. 39 1990 40 45
42. A. Beyer-Mears, F.P. Diecke, E. Cruz, and K. Mistry myo-Inositol transport in the lens of galactose-maintained rats Curr. Eye Res. 11 1992 25 34
43. V.N. Reddy, L.R. Lin, F.J. Giblin, B. Chakrapani, and T. Yokoyama Study of the polyol pathway and cell permeability changes in human lens and retinal pigment epithelium in tissue culture Invest. Ophthalmol. Vis. Sci. 33 1992 2334 2339
44. P.H. Whiting, K.P. Palmano, and J.N. Hawthorne Enzymes of myo-inositol and inositol lipid metabolism in rats with streptozotocin-induced diabetes Biochem. J. 179 1979 549 553
45. B. Nayak, P. Xie, S. Akagi, Q. Yang, L. Sun, J. Wada, A. Thakur, F.R. Danesh, S.S. Chugh, and Y.S. Kanwar Modulation of renal-specific oxidoreductase/myo-inositol oxygenase by high-glucose ambience Proc. Natl. Acad. Sci. U. S. A. 102 2005 17952 17957
46. Y. Xie, Q. Wang, J. Liu, J. Xie, K. Xue, and Q. Tang Dracorhodin perchlorate inhibit high glucose induce serum and glucocorticoid induced protein kinase 1 and fibronectin expression in human mesangial cells Zhongguo Zhong Yao Za Zhi 35 2010 1996 2000
47. R.S. Clements, and C.R. Stockard Abnormal sciatic nerve myo-inositol metabolism in the streptozotocin-diabetic rat: effect of insulin treatment Diabetes 29 1980 227 235
48. A.A. Sima, J.A. Dunlap, E.P. Davidson, T.J. Wiese, R.L. Lightle, D.A. Greene, and M.A. Yorek Supplemental myo-inositol prevents l-fucose-induced diabetic neuropathy Diabetes 46 1997 301 306
49. A.A. Sima, P.K. Thomas, D. Ishii, and A. Vinik Diabetic neuropathies Diabetologia 40 Suppl. 3 1997 B74 B77
50. J.G. Llewelyn The diabetic neuropathies: types, diagnosis and management J. Neurol. Neurosurg. Psychiatr. 74 Suppl. 2 2003 ii15 ii19
51. K. Oishi, B. Zheng, and J.F. Kuo Inhibition of Na, K-ATPase and sodium pump by protein kinase C regulators sphingosine, lysophosphatidylcholine, and oleic acid J. Biol. Chem. 265 1990 70 75
52. Y.S. Kanwar, J. Wada, L. Sun, P. Xie, E.I. Wallner, S. Chen, S. Chugh, and F.R. Danesh Diabetic nephropathy: mechanisms of renal disease progression Exp. Biol. Med. 233 2008 4 11
53. S. Suzuki, Y. Taneda, S. Hirai, S. Abe, A. Sasaki, K. Suzuki, and T. Toyota Molecular Mechanism of Insulin Resistance in Spontaneous Diabetic GK (Goto-Kakizaki) Rats New Directions in Research and Clinical Works for Obesity and Diabetes Mellitus 1991 Elsevier Science New York 197 203
54. J. Needham Studies on inositol: the synthesis of inositol in the animal body Biochem. J. 18 1924 891 904
55. W.H. Daughaday, J. Larner, and E. Houghton Thr renal excretion of inositol by normal and diabetic rats 1 J. Clin. Invest. 33 1954 1075 1080
56. H.K. Ortmeyer, N.L. Bodkin, K. Lilley, J. Larner, and B.C. Hansen Chiroinositol deficiency and insulin resistance I urinary excretion rate of chiroinositol is directly associated with insulin resistance in spontaneously diabetic rhesus monkeys Endocrinology 132 1993 640 645
57. J. Larner, and J.W. Craig Urinary myo-inositol-to-chiro-inositol ratios and insulin resistance Diabetes Care 19 1996 76 78
58. Y. Pak, C.R. Paule, Y.D. Bao, L.C. Huang, and J. Larner Insulin stimulates the biosynthesis of chiro-inositol-containing phospholipids in a rat fibroblast line expressing the human insulin receptor Proc. Natl. Acad. Sci. U. S. A. 90 1993 7759 7763
59. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome Fertil. Steril. 81 2004 19 25
60. A.A. Bremer Polycystic ovary syndrome in the pediatric population Metab. Syndr. Relat. Disord. 8 2010 375 394
61. E. Raffone, P. Rizzo, and V. Benedetto Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women Gynecol. Endocrinol. 26 2010 275 280
62. A.D. Genazzani, C. Lanzoni, F. Ricchieri, and V.M. Jasonni myo-Inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome Gynecol. Endocrinol. 24 2008 139 144
63. E. Papaleo, V. Unfer, J.-P. Baillargeon, L. De Santis, F. Fusi, C. Brigante, G. Marelli, I. Cino, A. Redaelli, and A. Ferrari myo-Inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction Gynecol. Endocrinol. 23 2007 700 703
64. S. Gerli, E. Papaleo, A. Ferrari, and G.C. Di Renzo Randomized, double blind placebo-controlled trial: effects of myo-inositol on ovarian function and metabolic factors in women with PCOS Eur. Rev. Med. Pharmacol. Sci. 11 2007 347 354
65. S. Gerli, M. Mignosa, and G.C. Di Renzo Effects of inositol on ovarian function and metabolic factors in women with PCOS: a randomized double blind placebo-controlled trial Eur. Rev. Med. Pharmacol. Sci. 7 2003 151 159
66. P.G. Artini, O.M. Di Berardino, F. Papini, A.D. Genazzani, G. Simi, M. Ruggiero, and V. Cela Endocrine and clinical effects of myo-inositol administration in policystyc ovary syndrome A randomized study Gynecol. Endocrinol. 2013 1 5
67. D. Costantino, G. Minozzi, E. Minozzi, and C. Guaraldi Metabolic and hormonal effects of myo-inositol in women with polycystic ovary syndrome: a double-blind trial Eur. Rev. Med. Pharmacol. Sci. 13 2009 105 110
68. R. Venturella, R. Mocciaro, E. De Trana, P. D'Alessandro, M. Morelli, and F. Zullo Assessment of the modification of the clinical, endocrinal and metabolical profile of patients with PCOS syndrome treated with myo-inositol Minerva Ginecol. 64 2012 239 243
69. B. Matarrelli, E. Vitacolonna, M. D'angelo, G. Pavone, P.A. Mattei, M. Liberati, and C. Celentano Effect of dietary myo-inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial J. Matern. Fetal Neonatal. Med. 2013
70. R. D'Anna, A. Scilipoti, D. Giordano, C. Caruso, M.L. Cannata, M.L. Interdonato, F. Corrado, and A. Di Benedetto myo-Inositol supplementation and onset of gestational diabetes mellitus in pregnant women with a family history of type 2 diabetes: a prospective, randomized, placebo-controlled study Diabetes Care 2013
71. A. Santamaria, D. Giordano, F. Corrado, B. Pintaudi, M.L. Interdonato, G.D. Vieste, A.D. Benedetto, and R. D'Anna One-year effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome Climacteric 15 2012 490 495
72. D. Giordano, F. Corrado, A. Santamaria, S. Quattrone, B. Pintaudi, A. Di Benedetto, and R. D'Anna Effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome: a perspective, randomized, placebo-controlled study Menopause 18 2011 102 104
73. F. Corrado, R. D'Anna, G. Di Vieste, D. Giordano, B. Pintaudi, A. Santamaria, and A. Di Benedetto The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes Diabet. Med. 28 2011 972 975
74. A.K. Gupta, S.R. Smith, F.L. Greenway, and G.A. Bray Pioglitazone treatment in type 2 diabetes mellitus when combined with portion control diet modifies the metabolic syndrome Diabetes Obes. Metab. 11 2009 330 337
75. K. Esposito, M. Ciotola, D. Carleo, B. Schisano, F. Saccomanno, F.C. Sasso, D. Cozzolino, R. Assaloni, D. Merante, A. Ceriello, and D. Giugliano Effect of rosiglitazone on endothelial function and inflammatory markers in patients with the metabolic syndrome Diabetes Care 29 2006 1071 1076
76. A. Fontbonne, I. Diouf, M. Baccara-Dinet, E. Eschwege, and M.-A. Charles Effects of 1-year treatment with metformin on metabolic and cardiovascular risk factors in non-diabetic upper-body obese subjects with mild glucose anomalies: a post-hoc analysis of the BIGPRO1 trial Diabetes Metab. 35 2009 385 391
77. S.H. Bates, R.B. Jones, and C.J. Bailey Insulin-like effect of pinitol Br. J. Pharmacol. 130 2000 1944 1948
78. M.-J. Kang, J.-I. Kim, S.-Y. Yoon, J.C. Kim, and I.-J. Cha Pinitol from soybeans reduces postprandial blood glucose in patients with type 2 diabetes mellitus J. Med. Food 9 2006 182 186
79. J.-I. Kim, J.C. Kim, M.-J. Kang, M.-S. Lee, J.-J. Kim, and I.-J. Cha Effects of pinitol isolated from soybeans on glycaemic control and cardiovascular risk factors in Korean patients with type II diabetes mellitus: a randomized controlled study Eur. J. Clin. Nutr. 59 2005 456 458
80. H. Shen, M. Shao, K.W. Cho, S. Wang, Z. Chen, L. Sheng, T. Wang, Y. Liu, and L. Rui Herbal constituent sequoyitol improves hyperglycemia and glucose intolerance by targeting hepatocytes, adipocytes, and β-cells Am. J. Physiol. Endocrinol. Metab. 302 2012 E932 E940
81. B.C. Hansen, H.L. Greene, H.K. Ortmeyer, Treatment of diabetes by myo-inositol administration, U.S. Patent 5736392, 1998.
82. D.A. Greene, P.V. De Jesus Jr., and A.I. Winegrad Effects of insulin and dietary myoinositol on impaired peripheral motor nerve conduction velocity in acute streptozotocin diabetes J. Clin. Invest. 55 1975 1326 1336
83. M.L. Croze, R.E. Vella, N.J. Pillon, H.A. Soula, L. Hadji, M. Guichardant, and C.O. Soulage Chronic treatment with myo-inositol reduces white adipose tissue accretion and improves insulin sensitivity in female mice J. Nutr. Biochem. 2012
84. N.T. Dang, R. Mukai, K.-I. Yoshida, and H. Ashida d-pinitol and myo-inositol stimulate translocation of glucose transporter 4 in skeletal muscle of C57BL/6 mice Biosci. Biotechnol. Biochem. 74 2010 1062 1067
85. J. Larner, L.C. Huang, G. Tang, S. Suzuki, C.F. Schwartz, G. Romero, Z. Roulidis, K. Zeller, T.Y. Shen, and A.S. Oswald Insulin mediators: structure and formation Cold Spring Harb. Symp. Quant. Biol. 53 Pt 2 1988 965 971
86. L.C. Huang, M.C. Fonteles, D.B. Houston, C. Zhang, and J. Larner Chiroinositol deficiency and insulin resistance III acute glycogenic and hypoglycemic effects of two inositol phosphoglycan insulin mediators in normal and streptozotocin-diabetic rats in vivo Endocrinology 132 1993 652 657
87. A.R. Saltiel, and P. Cuatrecasas Insulin stimulates the generation from hepatic plasma membranes of modulators derived from an inositol glycolipid PNAS 83 1986 5793 5797
88. D.R. Jones, and I. Varela-Nieto Diabetes and the role of inositol-containing lipids in insulin signaling Mol. Med. 5 1999 505 514
89. J. Larner, D.L. Brautigan, and M.O. Thorner d-chiro-Inositol glycans in insulin signaling and insulin resistance Mol. Med. 16 2010 543 552
90. F. Machicao, J. Mushack, E. Seffer, B. Ermel, and H.U. Häring Mannose, glucosamine and inositol monophosphate inhibit the effects of insulin on lipogenesis further evidence for a role for inositol phosphate- oligosaccharides in insulin action Biochem. J. 266 1990 909 916
91. K.L. Kelly, I. Merida, E.H. Wong, D. DiCenzo, and J.M. Mato A phospho-oligosaccharide mimics the effect of insulin to inhibit isoproterenol-dependent phosphorylation of phospholipid methyltransferase in isolated adipocytes J. Biol. Chem. 262 1987 15285 15290
92. R.V. Farese, M.L. Standaert, K. Yamada, L.C. Huang, C. Zhang, D.R. Cooper, Z. Wang, Y. Yang, S. Suzuki, and T. Toyota Insulin-induced activation of glycerol-3-phosphate acyltransferase by a chiro-inositol-containing insulin mediator is defective in adipocytes of insulin-resistant, type II diabetic, Goto-Kakizaki rats Proc. Natl. Acad. Sci. U. S. A. 91 1994 11040 11044
93. 2+ chelate with insulin-like activity J. Med. Chem. 46 2003 3283 3291
94. J. Larner, and L.C. Huang Identification of a novel inositol glycan signaling pathway with significant therapeutic relevance to insulin resistance: an insulin signaling model using both tyrosine kinase and G-proteins Diabetes Rev. 7 1999 217
95. G. Romero, G. Gámez, L.C. Huang, K. Lilley, and L. Luttrell Anti-inositolglycan antibodies selectively block some of the actions of insulin in intact BC3H1 cells Proc. Natl. Acad. Sci. U. S. A. 87 1990 1476 1480
96. G. Romero, J.C. Garmey, and J.D. Veldhuis The involvement of inositol phosphoglycan mediators in the modulation of steroidogenesis by insulin and insulin-like growth factor-I Endocrinology 132 1993 1561 1568
97. I. Varela, J.F. Alvarez, R. Clemente, J.M. Ruiz-Albusac, and J.M. Mato Asymmetric distribution of the phosphatidylinositol-linked phospho- oligosaccharide that mimics insulin action in the plasma membrane Eur. J. Biochem. 188 1990 213 218
98. M.-L. Hecht, Y.-H. Tsai, X. Liu, C. Wolfrum, and P.H. Seeberger Synthetic inositol phosphoglycans related to GPI lack insulin-mimetic activity ACS Chem. Biol. 2010
99. K.K. Reddy, J.R. Falck, and J. Capdevila Insulin second messengers: synthesis of 6-O-(2-amino-2-deoxy-α-d-glucopyranosyl)-d-chiro-inositol-1- phosphate Tetrahedron Lett. 34 1993 7869 7872
100. R. Plourde, M. D'Alarcao, and A.R. Saltiel Synthesis and characterization of an insulin-mimetic disaccharide J. Org. Chem. 57 1992 2606 2610
101. W. Frick, A. Bauer, J. Bauer, S. Wied, and G. Müller Structure-activity relationship of synthetic phosphoinositolglycans mimicking metabolic insulin action Biochemistry 37 1998 13421 13436
102. W. Frick, A. Bauer, J. Bauer, S. Wied, and G. Müller Insulin-mimetic signalling of synthetic phosphoinositolglycans in isolated rat adipocytes Biochem. J. 336 Pt 1 1998 163 181
103. A. Yap, S. Nishiumi, K.-I. Yoshida, and H. Ashida Rat L6 myotubes as an in vitro model system to study GLUT4-dependent glucose uptake stimulated by inositol derivatives Cytotechnology 55 2007 103 108
104. J.G. Salway, L. Whitehead, J.A. Finnegan, A. Karunanayaka, D. Barnett, and R.B. Payne Effect of myo-inositol on peripheral-nerve function in diabetes Lancet 2 1978 1282 1284
105. J.G. Jefferys, K.P. Palmano, A.K. Sharma, and P.K. Thomas Influence of dietary myoinositol on nerve conduction and inositol phospholipids in normal and diabetic rats J. Neurol. Neurosurg. Psychiatr. 41 1978 333 339
106. J.H. Mayer, and D.R. Tomlinson Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats Diabetologia 25 1983 433 438
107. F.N. Ziyadeh, D.A. Simmons, E.R. Snipes, and S. Goldfarb Effect of myo-inositol on cell proliferation and collagen transcription and secretion in proximal tubule cells cultured in elevated glucose J. Am. Soc. Nephrol. 1 1991 1220 1229
108. R.A. Cohen, L.C. MacGregor, K.C. Spokes, P. Silva, and F.H. Epstein Effect of myo-inositol on renal Na-K-ATPase in experimental diabetes Metab. Clin. Exp. 39 1990 1026 1032
109. A.M. Cohen, H. Wald, M. Popovtzer, and E. Rosenmann Effect of myo-inositol supplementation on the development of renal pathological changes in the Cohen diabetic (type 2) rat Diabetologia 38 1995 899 905
110. A. Beyer-Mears, F.A. Bucci Jr., M. Del Val, and E. Cruz Dietary myo-inositol effect on sugar cataractogenesis Pharmacology 39 1989 59 68